Brian Swann

Brian Swann serves as a key procurement professional within the CDC Office of Acquisition Services, supporting the agency’s mission to safeguard public health through strategic acquisition of critical biomedical and diagnostic capabilities. He manages a high-volume portfolio of contracts focused on pharmaceutical preparation, in-vitro diagnostic substances, and analytical laboratory instrumentation, ensuring timely delivery of tools essential for infectious disease surveillance, laboratory capacity building, and rapid public health response. His work directly enables CDC’s scientific operations by securing mission-critical supplies and services that underpin national health security initiatives. Swann maintains sustained contracting relationships with leading providers in the life sciences sector, including General Dynamics Information Technology, GlaxoSmithKline, Cepheid, MRIGLOBAL, and the New York City Health & Hospitals Corp. These partnerships reflect a preference for established industry leaders with proven capabilities in manufacturing, diagnostics, and large-scale public health support services. His contracting approach emphasizes technical compliance, regulatory alignment, and supply chain reliability, often involving complex procurements requiring FDA-regulated products and GMP-compliant production environments. Swann’s procurement portfolio reflects a strong orientation toward full and open competition, with 100% of awards issued without set-aside designations such as 8(a), HUBZone, or SDVOSB. This pattern indicates a strategic focus on acquiring specialized, high-precision goods and services where technical expertise and regulatory compliance take precedence over socioeconomic preferences, though small business participation may occur organically through subcontracting or teaming arrangements. His primary procurement focus lies in NAICS 325412 (Pharmaceutical Preparation Manufacturing), followed by 334516 (Analytical Laboratory Instrument Manufacturing) and 325413 (In-Vitro Diagnostic Substance Manufacturing). He specializes in acquiring reagents, diagnostic kits, automated lab systems, and associated support services essential for pathogen detection, genomic sequencing, and epidemiological data generation, demonstrating deep domain expertise in public health diagnostics and biomedical supply chain management.